BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Stem Cells. May 26, 2026; 18(5): 115482
Published online May 26, 2026. doi: 10.4252/wjsc.v18.i5.115482
Figure 4
Figure 4 Forkhead box P1 promoted the proliferation and self-renewal of spermatogonial stem cells via the nuclear factor kappa B pathway. A: Cell Counting Kit-8 assay showing the proliferation of spermatogonial stem cells (SSCs) in the control and sh-FOXP1 groups; B: Cell Counting Kit-8 assay showing the proliferation of SSCs in the control, nuclear factor kappa B (NF-κB) inhibitor (SC75741), FOXP1 overexpression (FOXP1-OE), and FOXP1-OE + NF-κB inhibitor groups; C: Western blot analysis showing the expression of proliferation and self-renewal proteins proliferating cell nuclear antigen, ETS variant gene 5, and promyelocytic leukemia zinc finger in the control and sh-FOXP1 groups; D: Western blot analysis showing the expression of proliferation and self-renewal proteins proliferating cell nuclear antigen, ETS variant gene 5, and promyelocytic leukemia zinc finger in the control, NF-κB inhibitor, FOXP1-OE, and FOXP1-OE + NF-κB inhibitor groups; E: Western blot analysis showing the expression of NF-κB p65 and phosphorylated-NF-κB p65 in the control and sh-FOXP1 groups; F: Western blot analysis showing the expression of NF-κB p65 and phosphorylated-NF-κB p65 in the control, NF-κB inhibitor, FOXP1-OE, and FOXP1-OE + NF-κB inhibitor groups. n ≥ 3, aP < 0.05, bP < 0.01, cP < 0.001. NS: Not significant; FOXP1: Forkhead box P1; NC: Negative control; ETV5: ETS variant gene 5; PLZF: Promyelocytic leukemia zinc finger; NF-κB: Nuclear factor kappa B; p-NF-κB p65: Phosphorylated nuclear factor kappa B p65; PCNA: Proliferating cell nuclear antigen.


Write to the Help Desk